Publication | Open Access

Discovery of novel hepatoselective HMG-CoA reductase inhibitors for treating hypercholesterolemia: A bench-to-bedside case study on tissue selective drug distribution

OxysterolBiochemistryMedicineBench-to-bedside Case StudyHyperlipidemiaPharmacotherapyPharmacologyAtherosclerosisDyslipidemiaDrug Discovery